HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 27.41
-2.22 (-7.49%)
At close: Jun 1, 2026
HitGen Employees
HitGen had 492 employees as of June 30, 2025. The number of employees increased by 9 or 1.86% since the number was reported on December 31, 2024.
Employees
492
Change
9
Growth
1.86%
Revenue / Employee
1.20M CNY
Profits / Employee
263.42K CNY
Market Cap
11.84B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 492 | 9 | 1.86% |
| Dec 31, 2024 | 483 | 31 | 6.86% |
| Dec 31, 2023 | 452 | -56 | -11.02% |
| Dec 31, 2022 | 508 | 37 | 7.86% |
| Dec 31, 2021 | 471 | 13 | 2.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Tibet Cheezheng Tibetan Medicine | 3,203 |
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Anhui Anke Biotechnology (Group) | 2,505 |
| Jinyu Bio-technology | 1,881 |
| Daan Gene | 1,730 |
| Mabwell (Shanghai) Bioscience | 1,325 |
| Inner Mongolia Furui Medical Science | 946 |